All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤ 2 cm non-small cell lung cancer.
Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser Altorki, Oliver S Chow
{"title":"All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤ 2 cm non-small cell lung cancer.","authors":"Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser Altorki, Oliver S Chow","doi":"10.1093/ejcts/ezaf082","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small cell lung cancer.</p><p><strong>Methods: </strong>A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤ 2 cm non-small cell lung cancers were included. Patients were grouped into single-segment and multi-segment resections. Patients were excluded if they had neuroendocrine tumors, small cell lung cancer, underwent wedge resection, or lobectomy. The primary outcome was loco-regional recurrence. Secondary outcomes of disease-free survival, loco-regional recurrence-free survival, overall survival, pathologic upstaging, and perioperative complications were evaluated.</p><p><strong>Results: </strong>190 (63.8%) patients had single-segment resection and 108 (36.2%) had multi-segment resection. The single-segment resection group had smaller tumors (1.3 vs 1.45 cm, p = 0.02), but no significant difference in margin length (1.7 vs 2 cm, p = 0.15). Fewer lymph nodes were resected in single-segment resection (7 vs 10, p < 0.001), and a significantly lower rate of pathologic upstaging (4.2% vs 10.2%, p = 0.03) was observed compared with multi-segment resection. Nevertheless, loco-regional recurrence developed in 6.3% of patients after single-segment resection and 7.4% patients following multi-segment resection (p = 0.72). With a median follow-up duration of 40 months, five-year disease-free survival, loco-regional recurrence-free survival, and overall survival was 73%, 89%, and 87% following single-segment resection compared to 78%, 95%, and 84% after multi-segment resection.</p><p><strong>Conclusions: </strong>For patients with clinical stage IA non-small cell lung cancers ≤2 cm, loco-regional recurrence and survival is not different based on whether patients receive a single-segment or multi-segment resection.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cardio-Thoracic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejcts/ezaf082","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small cell lung cancer.
Methods: A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤ 2 cm non-small cell lung cancers were included. Patients were grouped into single-segment and multi-segment resections. Patients were excluded if they had neuroendocrine tumors, small cell lung cancer, underwent wedge resection, or lobectomy. The primary outcome was loco-regional recurrence. Secondary outcomes of disease-free survival, loco-regional recurrence-free survival, overall survival, pathologic upstaging, and perioperative complications were evaluated.
Results: 190 (63.8%) patients had single-segment resection and 108 (36.2%) had multi-segment resection. The single-segment resection group had smaller tumors (1.3 vs 1.45 cm, p = 0.02), but no significant difference in margin length (1.7 vs 2 cm, p = 0.15). Fewer lymph nodes were resected in single-segment resection (7 vs 10, p < 0.001), and a significantly lower rate of pathologic upstaging (4.2% vs 10.2%, p = 0.03) was observed compared with multi-segment resection. Nevertheless, loco-regional recurrence developed in 6.3% of patients after single-segment resection and 7.4% patients following multi-segment resection (p = 0.72). With a median follow-up duration of 40 months, five-year disease-free survival, loco-regional recurrence-free survival, and overall survival was 73%, 89%, and 87% following single-segment resection compared to 78%, 95%, and 84% after multi-segment resection.
Conclusions: For patients with clinical stage IA non-small cell lung cancers ≤2 cm, loco-regional recurrence and survival is not different based on whether patients receive a single-segment or multi-segment resection.
期刊介绍:
The primary aim of the European Journal of Cardio-Thoracic Surgery is to provide a medium for the publication of high-quality original scientific reports documenting progress in cardiac and thoracic surgery. The journal publishes reports of significant clinical and experimental advances related to surgery of the heart, the great vessels and the chest. The European Journal of Cardio-Thoracic Surgery is an international journal and accepts submissions from all regions. The journal is supported by a number of leading European societies.